日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Knowledge, attitudes, and practices related to hypertension among Sri Lankans: an online cross-sectional survey

斯里兰卡人高血压相关知识、态度和行为:一项在线横断面调查

Ranasinghe, Priyanga; Weerasekara, Pumudu; Manchanayake, Minura; Liyanage, Sandamini; Perera, Thilina; Silva, Minollie; Webb, David J

Scottish and Newcastle Antiemetic Protocol (SNAP) 12-hour acetylcysteine regimen for paracetamol overdose reduces anaphylactoid reactions without compromising hepatic protection in all age groups: a secondary analysis

苏格兰和纽卡斯尔止吐方案(SNAP)12小时乙酰半胱氨酸治疗方案可降低对乙酰氨基酚过量引起的过敏样反应,且不损害所有年龄组的肝脏保护作用:一项二次分析

Humphries, Christopher; Pettie, Janice; Agboola, Bridget; Caparrotta, Thomas M; Hunter, Robert W; Morrison, Emma; Sandilands, Euan A; Webb, David J; Eddleston, Michael; Dear, James

Adipocyte endothelin B receptor activation inhibits adiponectin production and causes insulin resistance in obese mice

脂肪细胞内皮素B受体激活抑制脂联素生成,导致肥胖小鼠出现胰岛素抵抗。

Rivera-Gonzalez, Osvaldo; Mills, Megumi F; Konadu, Bridget D; Wilson, Natalie A; Murphy, Hayley A; Newberry, Madison K; Hyndman, Kelly A; Garrett, Michael R; Webb, David J; Speed, Joshua S

Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy)

在安慰剂对照、随机、交叉试验中,对乙酰氨基酚治疗剂量(PATH-BP 生物标志物子研究)显示,细胞角蛋白-18 是丙氨酸转氨酶升高的敏感生物标志物。

Scullion, Kathleen M; MacIntyre, Iain M; Sloan-Dennison, Sian; Clark, Benjamin; Fineran, Paul; Mair, Joanne; Creasey, David; Rathmell, Cicely; Faulds, Karen; Graham, Duncan; Webb, David J; Dear, James W

The effect of daily UVA phototherapy for 2 weeks on clinic and 24-h blood pressure in individuals with mild hypertension

每日接受UVA光疗2周对轻度高血压患者诊室血压和24小时血压的影响

Weller, Richard B; Macintyre, Iain M; Melville, Vanessa; Farrugia, Michael; Feelisch, Martin; Webb, David J

Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial

英国成人高血压患者服用常规降压药时,晚上服用与早上服用对心血管结局的影响(TIME 研究):一项前瞻性、随机、开放标签、盲法终点临床试验

Mackenzie, Isla S; Rogers, Amy; Poulter, Neil R; Williams, Bryan; Brown, Morris J; Webb, David J; Ford, Ian; Rorie, David A; Guthrie, Greg; Grieve, J W Kerr; Pigazzani, Filippo; Rothwell, Peter M; Young, Robin; McConnachie, Alex; Struthers, Allan D; Lang, Chim C; MacDonald, Thomas M

Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial

高血压患者规律服用对乙酰氨基酚与血压的关系:PATH-BP试验

MacIntyre, Iain M; Turtle, Emma J; Farrah, Tariq E; Graham, Catriona; Dear, James W; Webb, David J

De-risking Clinical Trials: The BIAL Phase I Trial in Foresight

降低临床试验风险:BIAL I期试验展望

Cohen, Adam F; van Smeden, Jeroen; Webb, David J

Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor-Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen-Targeting Small Interfering RNA

高血压小干扰RNA疗法:关于血管加压药和血管加压药替代策略对抗血管紧张素原靶向小干扰RNA降低血压的观点

Ranasinghe, Priyanga; Addison, Melisande L; Webb, David J

The acute pressure natriuresis response is suppressed by selective ETA receptor blockade.

选择性 ETA 受体阻断可抑制急性压力性利钠反应

Culshaw Geoffrey, Binnie David, Dhaun Neeraj, Hadoke Patrick, Bailey Matthew, Webb David J